Stryker devices, including its Mako robot for total joint replacements, have been added in several ASCs over the last year.
While the company’s sales grew 11.5% for its med-surg and neurotechnology applications, they grew 10.5% for its orthopedic and spine applications.
Stryker now expects its organic net sales to grow 7.5% to 9% in 2024, according to a Jan. 30 news release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.